A new breakthrough in screening for lung cancer will reveal risks far earlier. Researchers at Moffitt Cancer Center have innovated a new test based on CT scans that promises to help save lives.
CT scans are great for lung cancer screening, but small abnormalities test as negative for many patients. Unfortunately, when these patients do develop lung cancer, their outcomes are poor.
Moffitt researchers believe that certain biomarkers can show which patients with a negative CT scan are at greater risk for developing lung cancer. And when it’s detected earlier, the outcome is much better. “Lung cancer screening participants may represent a more vulnerable population,” says Matthew Schabath, Ph.D. “Image-based biomarkers could assist in identifying high-risk participants.”
This is your support at work to push forward the latest cancer research. You’re helping to save more lives.